Search

everythinglearnresearchcommunity

for

Search:↓

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Vitamin D receptor gene variations are not linked to alopecia areata.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

The paper concludes that copying the natural direction and angle of hair in transplants is key for a natural look and doesn't harm hair survival.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Alopecia areata is not linked to vitamin B12 deficiency.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Fexofenadine may help treat alopecia areata.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Dupilumab for skin problems might reactivate hair loss in some patients.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Low vitamin D levels are common in people with Alopecia Areata.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Topical 1% sildenafil is not recommended for treating alopecia areata in children.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.